Canopy Growth expands European medical cannabis supply into the U.K.
Canopy Growth reached an agreement to supply four Canadian-grown medical flower strains to a cannabis-based medicines maker that will commercialize them under Canopy’s Spectrum Therapeutics brand in the U.K.
K. market, supplying four Canadian-grown medical flower strains to a maker of cannabis-based medicines. The partner will commercialize the products under Canopy's Spectrum Therapeutics brand.